- Home
- BLBD vs KNSA Comparison
BLBD vs KNSA Comparison
Compare BLBD & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLBD
- KNSA
- Stock Information
- Founded
- BLBD 1927
- KNSA 2015
- Country
- BLBD United States
- KNSA United Kingdom
- Employees
- BLBD N/A
- KNSA N/A
- Industry
- BLBD Construction/Ag Equipment/Trucks
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- BLBD Consumer Discretionary
- KNSA Health Care
- Exchange
- BLBD Nasdaq
- KNSA Nasdaq
- Market Cap
- BLBD 1.5B
- KNSA 1.7B
- IPO Year
- BLBD N/A
- KNSA 2018
- Fundamental
- Price
- BLBD $41.18
- KNSA $21.28
- Analyst Decision
- BLBD Strong Buy
- KNSA Strong Buy
- Analyst Count
- BLBD 7
- KNSA 5
- Target Price
- BLBD $60.14
- KNSA $36.60
- AVG Volume (30 Days)
- BLBD 889.9K
- KNSA 365.0K
- Earning Date
- BLBD 11-25-2024
- KNSA 10-29-2024
- Dividend Yield
- BLBD N/A
- KNSA N/A
- EPS Growth
- BLBD N/A
- KNSA N/A
- EPS
- BLBD 3.02
- KNSA N/A
- Revenue
- BLBD $1,299,905,000.00
- KNSA $384,098,000.00
- Revenue This Year
- BLBD $18.91
- KNSA $60.05
- Revenue Next Year
- BLBD $10.10
- KNSA $36.32
- P/E Ratio
- BLBD $13.64
- KNSA N/A
- Revenue Growth
- BLBD 19.53
- KNSA 54.41
- 52 Week Low
- BLBD $17.79
- KNSA $15.52
- 52 Week High
- BLBD $59.40
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- BLBD 49.01
- KNSA 36.27
- Support Level
- BLBD $36.86
- KNSA $20.41
- Resistance Level
- BLBD $43.01
- KNSA $21.55
- Average True Range (ATR)
- BLBD 2.13
- KNSA 0.84
- MACD
- BLBD 0.15
- KNSA -0.10
- Stochastic Oscillator
- BLBD 61.22
- KNSA 28.02
About BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It has its operations in two segments. The Bus segment involves the design, engineering, manufacture and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. It carries its operations in the United States, Canada, and the rest of the world. The majority of its sales are derived from the United States through its bus manufacturing business.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.